Bionano Genomics Inc (NAS:BNGO)
$ 0.967 -0.0042 (-0.43%) Market Cap: 66.83 Mil Enterprise Value: 52.29 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 46/100

Q2 2021 Bionano Genomics Inc Earnings Call Transcript

Aug 04, 2021 / 08:30PM GMT
Release Date Price: $58.6 (-1.01%)
Operator

Good day, and welcome to the Bionano Genomics Second Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead.

Amy Conrad

Thank you, Laura, and good afternoon, everyone. Welcome to the Bionano Genomics Second Quarter 2021 Financial Results Conference Call. Leading the call today is Dr. Erik Holmlin, CEO of Bionano, is joined by Chris Stewart, CFO of Bionano and Dr. Alka Chaubey, CMO of Bionano. After market close today, Bionano issued a press release announcing its financial results for the second quarter of 2021. A copy of the release can be found on the Investor Relations page of the company's website.

I would like to remind everyone that certain statements made during this conference call may be forward-looking including statements about Bionano's strategic and commercialization plans, sales pipeline, anticipated benefits or improvements to the Saphyr system, anticipated milestones for 2021 and the advantages of the Saphyr

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot